A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease - Nature Medicine

S.S. was the Project Arm Leader for the gantenerumab arm. He also receives research support and is a consultant to Eisai, Novartis, Genentech, F. Hoffmann-La Roche Ltd, GemVax, Avid Radiopharmaceuticals and Eli Lilly and Company. M. Farlow was the Project Arm Leader for the solanezumab arm. He receives research support and is consultant to Eli Lilly and Company, Eisai, Novartis, Green Valley, AbbVie, Biogen, Eisai, F.

He receives research support from the NIH and the Alexander Family Alzheimer’s Disease Research Professorship of the Mayo Clinic. C.C. receives research support from Biogen, Eisai, Alector and Parabon. C.C. is a member of the advisory board of Vivid Genetics, Halia Therapeutics and ADx Healthcare. C.M. is a consultant for Biogen. L.S.H. is a consultant for Cortexyme, Eisai, Eli Lilly and Company, Medscape and Prevail.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

A randomized controlled trial to test financial incentives for COVID-19 vaccination in Ghana - Nature MedicineA randomized controlled trial to test financial incentives for COVID-19 vaccination in Ghana. Correspondence from pmc868 and colleagues Oxford_NDPH UnivofGh
Source: NatureMedicine - 🏆 451. / 53 Read more »

Questions of accountability and transparency in the US organ donation and transplantation system - Nature MedicineQuestions of accountability and transparency in the US organ donation and transplantation system. Correspondence from DrMaceyLevan and colleagues nyugrossman nyulangone
Source: NatureMedicine - 🏆 451. / 53 Read more »

Diversity, equity and inclusion actions from the NCATS Clinical and Translational Science awarded programs - Nature MedicineDiversity, equity and inclusion actions from the NCATS Clinical and Translational Science awarded programs. Correspondence from L. Ebony Boulware and colleagues DukeMedSchool
Source: NatureMedicine - 🏆 451. / 53 Read more »

How better pandemic and epidemic intelligence will prepare the world for future threats - Nature MedicineA new approach to pandemic and epidemic intelligence is needed that includes modern approaches to surveillance and risk assessment, as well as improved trust and cooperation between stakeholders and society. OWMorgan Chikwe_I WHO OWMorgan Chikwe_I WHO OWMorgan Chikwe_I WHO
Source: NatureMedicine - 🏆 451. / 53 Read more »

Virtual conferences democratize access to science - Nature MedicineOnline access during the pandemic widened participation in scientific conferences for women, young scientists and those from low- and middle-income countries, and should be continued
Source: NatureMedicine - 🏆 451. / 53 Read more »